Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by everolimus.

Liu L, Gong L, Zhang Y, Li N.

Exp Ther Med. 2013 Jan;5(1):338-342. Epub 2012 Nov 1.

2.

The mTOR inhibitor AZD8055 inhibits proliferation and glycolysis in cervical cancer cells.

Li S, Li Y, Hu R, Li W, Qiu H, Cai H, Wang S.

Oncol Lett. 2013 Feb;5(2):717-721. Epub 2012 Dec 4.

3.

Everolimus and mycophenolate mofetil sensitize human pancreatic cancer cells to gemcitabine in vitro: a novel adjunct to standard chemotherapy?

Tuncyurek P, Mayer JM, Klug F, Dillmann S, Henne-Bruns D, Keller F, Stracke S.

Eur Surg Res. 2007;39(6):380-7. Epub 2007 Aug 14.

PMID:
17700025
4.

Propofol inhibits growth and invasion of pancreatic cancer cells through regulation of the miR-21/Slug signaling pathway.

Liu Z, Zhang J, Hong G, Quan J, Zhang L, Yu M.

Am J Transl Res. 2016 Oct 15;8(10):4120-4133. eCollection 2016.

5.

S100A11 promotes human pancreatic cancer PANC-1 cell proliferation and is involved in the PI3K/AKT signaling pathway.

Xiao M, Li T, Ji Y, Jiang F, Ni W, Zhu J, Bao B, Lu C, Ni R.

Oncol Lett. 2018 Jan;15(1):175-182. doi: 10.3892/ol.2017.7295. Epub 2017 Oct 31.

6.

Pharmacological targeting of mammalian target of rapamycin inhibits ovarian granulosa cell tumor growth.

Rico C, Laguë MN, Lefèvre P, Tsoi M, Dodelet-Devillers A, Kumar V, Lapointe E, Paquet M, Nadeau MÈ, Boerboom D.

Carcinogenesis. 2012 Nov;33(11):2283-92. doi: 10.1093/carcin/bgs263. Epub 2012 Aug 7.

PMID:
22871496
7.

miR-4458 suppresses glycolysis and lactate production by directly targeting hexokinase2 in colon cancer cells.

Qin Y, Cheng C, Lu H, Wang Y.

Biochem Biophys Res Commun. 2016 Jan 1;469(1):37-43. doi: 10.1016/j.bbrc.2015.11.066. Epub 2015 Nov 25.

PMID:
26607110
8.

STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells.

Li M, Jin R, Wang W, Zhang T, Sang J, Li N, Han Q, Zhao W, Li C, Liu Z.

Oncotarget. 2017 Apr 11;8(15):24777-24784. doi: 10.18632/oncotarget.15801.

9.

High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells.

Li WG, Yuan YZ, Qiao MM, Zhang YP.

World J Gastroenterol. 2012 Jun 7;18(21):2630-9. doi: 10.3748/wjg.v18.i21.2630.

10.

microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression.

Liu Z, Du R, Long J, Guo K, Ge C, Bi S, Xu Y.

Chin J Cancer Res. 2015 Jun;27(3):267-78. doi: 10.3978/j.issn.1000-9604.2015.04.06.

11.

Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.

Xu Z, Zhang Y, Jiang J, Yang Y, Shi R, Hao B, Zhang Z, Huang Z, Kim JW, Zhang G.

BMC Cancer. 2010 Apr 27;10:161. doi: 10.1186/1471-2407-10-161.

12.

Propofol suppresses proliferation and invasion of pancreatic cancer cells by upregulating microRNA-133a expression.

Wang ZT, Gong HY, Zheng F, Liu DJ, Dong TL.

Genet Mol Res. 2015 Jul 6;14(3):7529-37. doi: 10.4238/2015.July.3.28.

13.

Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes.

Papadopoulos EI, Yousef GM, Scorilas A.

Biomed Pharmacother. 2015 Mar;70:33-40. doi: 10.1016/j.biopha.2014.12.043. Epub 2015 Jan 9.

PMID:
25776476
14.

Glycolytic enzyme inhibitors affect pancreatic cancer survival by modulating its signaling and energetics.

Bhardwaj V, Rizvi N, Lai MB, Lai JC, Bhushan A.

Anticancer Res. 2010 Mar;30(3):743-9.

PMID:
20392992
15.

Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis.

Wang B, Wang XB, Chen LY, Huang L, Dong RZ.

Biochem Biophys Res Commun. 2013 Jul 19;437(1):1-6. doi: 10.1016/j.bbrc.2013.05.090. Epub 2013 Jun 4.

PMID:
23743198
16.

MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).

Wu D, Huang HJ, He CN, Wang KY.

Int J Gynecol Cancer. 2013 Sep;23(7):1191-7. doi: 10.1097/IGC.0b013e31829ea779.

PMID:
23851675
17.

MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.

Janaki Ramaiah M, Lavanya A, Honarpisheh M, Zarea M, Bhadra U, Bhadra MP.

Gene. 2014 Dec 1;552(2):255-64. doi: 10.1016/j.gene.2014.09.052. Epub 2014 Sep 26.

PMID:
25261849
18.

Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in BXPC-3 and PANC-1 human pancreatic cancer cells.

Wang L, Zhu ZX, Zhang WY, Zhang WM.

Exp Ther Med. 2011 Sep;2(5):969-975. Epub 2011 Jun 22.

19.

PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells.

Liu S, Wang XJ, Liu Y, Cui YF.

Am J Chin Med. 2013;41(3):629-42. doi: 10.1142/S0192415X13500444.

PMID:
23711146
20.

Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.

Zhu ZW, Friess H, Wang L, Bogardus T, Korc M, Kleeff J, Büchler MW.

Clin Cancer Res. 2001 Jan;7(1):105-12.

Supplemental Content

Support Center